Article
Deaths from prostate cancer are on the decline, but why?
Atlanta-Patients and physicians are winning the battle against prostate cancer, new data show. What's not so clear-cut, though, is the reason why.
Related Videos
Karyn S. Eilber, MD, shares her reaction to genitourinary syndrome of menopause guidelines
Expert discusses the relationship between RCTs and real-world efficacy of prostate cancer treatments
Treatment Decisions in Patients With Low- vs High-Volume Disease
Findings in the Docetaxel-Naive Patient Population
Endourologist discusses shared decision-making and laser lithotripsy
Shreyas Joshi, MD, recaps AUA session on chemotherapy vs novel NMIBC options
Joshua J. Meeks, MD, PhD, discusses NIAGARA data for patient undergoing cystectomy
Shay Rajavel, MS3, on CO2 gas embolism during single-port partial nephrectomy
Kevin Zorn, MD, on preserving ejaculation with BPH therapies
Neal Shore, MD, on sasanlimab plus BCG for BCG-naïve NMIBC
Related Content
